MTHFR C677T Mutation and Fetal Loss
Author Information
Author(s): Ivy Altomare, Alan Adler, Louis M Aledort
Primary Institution: Mount Sinai Medical Center
Hypothesis
The relationship between methylenetetrahydrofolate reductase C677T homozygosity and risk of recurrent spontaneous abortion is unknown.
Conclusion
The study provides evidence that MTHFR C677T mutations are associated with recurrent fetal loss and that anticoagulation during pregnancy can lead to successful outcomes.
Supporting Evidence
- Two women had successful full-term deliveries on LMW heparin.
- One woman is currently pregnant in her third trimester with no complications after receiving LMW heparin.
- Five patients are trying to conceive after being recommended LMW heparin upon conception.
Takeaway
Some women with a specific gene mutation might have trouble keeping their babies, but giving them a special medicine during pregnancy can help them have healthy babies.
Methodology
The study involved 8 patients who were homozygous for the MTHFR C677T mutation and had histories of spontaneous fetal loss, with treatment involving low-molecular weight heparin.
Limitations
The study is a case series and lacks randomized controlled trials to definitively establish the effectiveness of anticoagulation in these patients.
Participant Demographics
The mean age of participants was 36 years, with a history of 1 to 6 previous miscarriages.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website